PortfoliosLab logoPortfoliosLab logo
ATEYY vs. ASND
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ATEYY vs. ASND - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Advantest Corp DRC (ATEYY) and Ascendis Pharma A/S (ASND). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ATEYY achieves a 38.53% return, which is significantly higher than ASND's 2.26% return. Over the past 10 years, ATEYY has outperformed ASND with an annualized return of 52.65%, while ASND has yielded a comparatively lower 33.14% annualized return.


ATEYY

1D
4.13%
1M
2.59%
YTD
38.53%
6M
38.14%
1Y
197.06%
3Y*
71.51%
5Y*
50.50%
10Y*
52.65%

ASND

1D
1.14%
1M
-9.33%
YTD
2.26%
6M
-1.07%
1Y
27.67%
3Y*
32.88%
5Y*
10.86%
10Y*
33.14%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ATEYY vs. ASND - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ATEYY
Advantest Corp DRC
38.53%122.70%68.99%111.43%-33.43%27.37%30.96%176.84%12.51%12.66%
ASND
Ascendis Pharma A/S
2.26%54.89%9.31%3.13%-9.22%-19.34%19.88%122.06%56.39%97.92%

Correlation

The correlation between ATEYY and ASND is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Jan 4, 2016

0.12

Fundamentals

Market Cap

ATEYY:

$127.67B

ASND:

$14.07B

EPS

ATEYY:

¥520.21

ASND:

€8.08

PE Ratio

ATEYY:

53.89

ASND:

23.32

PEG Ratio

ATEYY:

0.69

ASND:

0.11

PS Ratio

ATEYY:

17.92

ASND:

13.62

PB Ratio

ATEYY:

25.59

ASND:

24.89

Total Revenue (TTM)

ATEYY:

¥1.14T

ASND:

€867.51M

Gross Profit (TTM)

ATEYY:

¥736.09B

ASND:

€764.89M

EBITDA (TTM)

ATEYY:

¥533.69B

ASND:

-€6.94M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ATEYY vs. ASND — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATEYY
ATEYY Risk / Return Rank: 9393
Overall Rank
ATEYY Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
ATEYY Sortino Ratio Rank: 9191
Sortino Ratio Rank
ATEYY Omega Ratio Rank: 8989
Omega Ratio Rank
ATEYY Calmar Ratio Rank: 9494
Calmar Ratio Rank
ATEYY Martin Ratio Rank: 9494
Martin Ratio Rank

ASND
ASND Risk / Return Rank: 6868
Overall Rank
ASND Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
ASND Sortino Ratio Rank: 6363
Sortino Ratio Rank
ASND Omega Ratio Rank: 6060
Omega Ratio Rank
ASND Calmar Ratio Rank: 7272
Calmar Ratio Rank
ASND Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATEYY vs. ASND - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Advantest Corp DRC (ATEYY) and Ascendis Pharma A/S (ASND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ATEYYASNDDifference
Sharpe ratioReturn per unit of total volatility

+2.11

Sortino ratioReturn per unit of downside risk

+1.87

Omega ratioGain probability vs. loss probability

1.39

1.15

+0.23

Calmar ratioReturn relative to maximum drawdown

6.07

1.59

+4.48

Martin ratioReturn relative to average drawdown

16.34

4.87

+11.47

ATEYY vs. ASND - Sharpe Ratio Comparison

The current ATEYY Sharpe Ratio is 2.87, which is higher than the ASND Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of ATEYY and ASND, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ATEYY vs. ASND - Drawdown Comparison

The maximum ATEYY drawdown since its inception was -56.48%, smaller than the maximum ASND drawdown of -61.72%. Use the drawdown chart below to compare losses from any high point for ATEYY and ASND.


Loading charts...

Drawdown Indicators


ATEYYASNDDifference

Max Drawdown

Largest peak-to-trough decline

-56.48%

-61.72%

+5.24%

Max Drawdown (1Y)

Largest decline over 1 year

-33.24%

-17.62%

-15.62%

Max Drawdown (3Y)

Largest decline over 3 years

-44.70%

-29.15%

-15.55%

Max Drawdown (5Y)

Largest decline over 5 years

-56.48%

-60.46%

+3.98%

Max Drawdown (10Y)

Largest decline over 10 years

-56.48%

-61.72%

+5.24%

Current Drawdown

Current decline from peak

-11.76%

-12.72%

+0.96%

Average Drawdown

Average peak-to-trough decline

-14.23%

-18.90%

+4.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.32%

5.72%

+6.60%

Volatility

ATEYY vs. ASND - Volatility Comparison

Advantest Corp DRC (ATEYY) has a higher volatility of 27.35% compared to Ascendis Pharma A/S (ASND) at 13.12%. This indicates that ATEYY's price experiences larger fluctuations and is considered to be riskier than ASND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ATEYYASNDDifference

Volatility (1M)

Calculated over the trailing 1-month period

27.35%

13.12%

+14.23%

Volatility (6M)

Calculated over the trailing 6-month period

55.16%

29.45%

+25.71%

Volatility (1Y)

Calculated over the trailing 1-year period

70.37%

37.26%

+33.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.29%

48.65%

+4.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.58%

51.09%

-2.51%

Dividends

ATEYY vs. ASND - Dividend Comparison

Neither ATEYY nor ASND has paid dividends to shareholders.


PositionTTM2025202420232022202120202019201820172016
ASND
Ascendis Pharma A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ATEYY
Advantest Corp DRC
0.00%0.11%0.22%0.00%0.00%0.00%0.00%0.00%0.00%1.18%1.24%

Financials

ATEYY vs. ASND - Financials Comparison

This section allows you to compare key financial metrics between Advantest Corp DRC and Ascendis Pharma A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00B100.00B150.00B200.00B250.00B300.00B350.00B20222023202420252026
334.10B
250.66M
(ATEYY) Total Revenue
(ASND) Total Revenue
Please note, different currencies. ATEYY values in JPY, ASND values in EUR

Frequently Asked Questions


ATEYY and ASND have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ATEYY has higher volatility (27.35%) compared to ASND (13.12%). In terms of maximum drawdown, ATEYY dropped -56.48% vs ASND's -61.72%.

ATEYY currently has the higher Sharpe Ratio (2.87 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ATEYY and ASND

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer